Cruzersoftech
Tasso raises $17M for self-sample blood test; CEO says pandemic increases demand for at-home tests
Health

Tasso raises $17M for self-sample blood test; CEO says pandemic increases demand for at-home tests

Seattle startup Tasso closed a $17 million funding spherical to assist develop its at-home blood assortment platform.

The corporate’s blood pattern machine, known as Tasso OnDemand, lets folks take their very own blood at residence and mail it to a lab instantly quite than go to a clinic. This enables for extra frequent testing to observe a drug’s results on the blood, for instance, and in addition lets folks submit samples with out going right into a bodily workplace.

Tasso was began by Dr. Ben Casavant and Dr. Erwin Berthier, who each acquired doctorates in biomedical engineering from the College of Wisconsin-Madison.

“The coronavirus pandemic has underscored the surging demand for extra diagnostic options which might be patient-friendly and will be deployed simply at residence,” Casavant, the corporate’s CEO, mentioned in an announcement. “The Tasso OnDemand gadgets are enabling folks to be examined for COVID-19 and plenty of different routine diagnostic functions, from wherever at any time.”

Tasso has pilot packages with the Fred Hutchinson Most cancers Analysis Heart in Seattle, Cedars-Sinai, and others. It’s working with Fred Hutch to check for COVID-19 antibodies in serum as a part of a examine, with samples being mailed again from sufferers who don’t want to come back right into a clinic.

The 8-year-old firm and Techstars grad developed its platform utilizing $13.1 million of grant funding from the Protection Superior Analysis Tasks Company (DARPA), the Protection Menace Discount Company (DTRA) and the Nationwide Institute of Well being (NIH).

Quest and LabCorp dominate the diagnostics trade, which a variety of startups have tried to disrupt via at-home or direct-to-consumer testing. EverlyWell, a startup that acquired funding via “Shark Tank” and presents a menu of well being tests primarily based on samples collected at residence, has drawn scrutiny from experts over its accuracy. EveryWell sells an FDA-approved COVID-19 at-home test.

Different rivals embrace Scanwell, Thriva, WellnessFX, Baze, myLAB, LetsGetChecked, and extra. A pair of Portland startup vets recently launched Reperio Health, a subscription service that may ship a package containing gadgets for testing well being metrics.

Hambrecht Ducera Development Ventures led the Collection A spherical, which included participation from Foresite Capital, Merck World Well being Innovation Fund, Vertical Enterprise Companions, Techstars, and Cedars-Sinai. Elizabeth Hambrecht, associate at Hambrecht Ducera Development Ventures, has joined Tasso’s board.

“With its gifted crew and confirmed expertise platform, Tasso is poised to rework the standard, painful, in-person blood draw course of, which has been the usual of care for the previous six a long time,” Hambrecht mentioned in an announcement.

Up to now, Tasso has raised $38.6 million up to now in grants, non-public investments, and co-development collaborations. It beforehand raised a $6.1 million round in March 2019.

Related posts

How Long the COVID-19 Virus Lasts on Surfaces: New Research on SARS-CoV-2 “Survivability”

cruzer

Fast, Portable COVID-19 Test Could Bypass the Lab

cruzer

Preventing Heart Infection From Mouth Bacteria With Good Dental Health

cruzer